An appealing new therapeutic for ulcerative colitis?

Gut

Volumn 63, Issue 8, 2014, Pages 1207-1208

  McKernan, Declan P ^a   Finn, David P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; DEXTRAN SULFATE; FATTY ACID AMIDASE INHIBITOR; NEUROKININ A; NITRIC OXIDE SYNTHASE; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN S100B; SUBSTANCE P; TOLL LIKE RECEPTOR 4; CYTOKINE; FATTY ACID AMIDASE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; BLOOD FLOW; CALCIUM HOMEOSTASIS; CELL INFILTRATION; CELL MOTILITY; CELL PROLIFERATION; CELLULAR SECRETION; CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; CYTOKINE RELEASE; DISEASE ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENTERIC GLIAL CELL; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MOUSE; NONHUMAN; NOTE; NUTRIENT UPTAKE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; DRUG EFFECT; DRUG MECHANISM; IMMUNOCOMPETENT CELL;

INFLAMMATION; INFLAMMATORY BOWEL DISEASE; PHARMACOLOGY; ULCERATIVE COLITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; ENDOCANNABINOIDS; ETHANOLAMINES; FEMALE; HUMANS; MALE; NEUROGLIA; PALMITIC ACIDS; PPAR ALPHA; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; TOLL-LIKE RECEPTOR 4;

EID: 84886179715     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305929     Document Type: Note

References (11)

1. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361:2066-78.
2. Ruhl A, Nasser Y, Sharkey KA. Enteric glia. Neurogastroenterol Motil 2004;16(Suppl 1):44-9. (Pubitemid 38580940)
3. Cirillo C, Sarnelli G, Esposito G, et al. S100B protein in the gut: The evidence for enteroglial-sustained intestinal inflammation. World J Gastroenterol 2011;17:1261-6.
4. Donato R, Cannon BR, Sorci G, et al. Functions of S100 proteins. Curr Mol Med 2013;13:24-57.
5. Cirillo C, Sarnelli G, Esposito G, et al. Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. Neurogastroenterol Motil 2009;21:1209-112.
6. Turco F, Sarnelli G, Cirillo C, et al. Enteroglial-derived S100B protein integrates bacteria-induced Toll-like receptor signalling in human enteric glial cells. Gut 2014;63:105-15.
7. Esposito G, Capoccia E, Turco F, et al. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR- Alpha activation. Gut 2014;63:1300-12.
8. Petrosino S, Iuvone T, Di Marzo V. N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities. Biochimie 2010;92:724-7.
9. Alhouayek M, Muccioli GG. The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity. Trends Mol Med 2012;18:615-25.
10. Eijkelkamp N, Kavelaars A, Elsenbruch S, et al. Increased visceral sensitivity to capsaicin after DSS-induced colitis in mice: spinal cord c-Fos expression and behavior. Am J Physiol Gastrointest Liver Physiol 2007;293:749-57.
11. Hesselink JM, Hekker TA. Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: A case series. J Pain Res 2012;5:437-42.